Reducing l-cysteine degradation in E
& Dennis, E
and his institution has received research grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Faraday, Gilead, Idorsia, Janssen, Matsutani Chemical Industry Co, Merck, Novartis, and the Scott R
A.LieberfarbM
Currently, only patients with diabetes and similar conditions can have GLP-1 medications covered under Medicare, but the official said the expanded coverage will allow the medications to be prescribed for patients who are overweight, with pre-diabetes or established cardiovascular disease, as well as patients with obesity and uncontrolled hypertension, kidney disease, [or] heart failure with a Body Mass Index greater than 27